Market Exclusive

Analyst Activity – Needham & Company LLC Reiterates Buy on AtriCure (NASDAQ:ATRC)

Analyst Ratings For AtriCure (NASDAQ:ATRC)

Today, Needham & Company LLC reiterated its Buy rating on AtriCure (NASDAQ:ATRC) with a price target of $26.00.

There are 1 hold rating, 7 buy ratings on the stock.

The current consensus rating on AtriCure (NASDAQ:ATRC) is Buy (Score: 2.88) with a consensus target price of $23.38 per share, a potential 3.02% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For AtriCure (NASDAQ:ATRC)
AtriCure (NASDAQ:ATRC) has insider ownership of 10.00% and institutional ownership of 86.46%.

Recent Trading Activity for AtriCure (NASDAQ:ATRC)
Shares of AtriCure closed the previous trading session at 22.69 down -0.45 -1.94% with 281,453 shares trading hands.

Exit mobile version